Skip to content
DaveManuel.com · Institutional Ownership · Hedge Fund Highlight

H.B. Fuller: Two Activists, Two Rejected Bids and a Board That Started Buying

Ancora and Engine built their stakes, all eight independent directors bought shares, and the stock closed at a 52-week low on November 20. What the filings show, and the dates that matter over the next five months.

Hedge Fund Highlight No. 1 · Published November 21, 2026 · Prices at the November 20, 2026 close

$46.24Close, November 20, 202652-week range $46.11 to $68.63
~5.5%Held by Ancora and Engine13F filings, September 30, 2026
$1.15MInsider buying, Sep 28 to Oct 16Eight directors and one executive
7.7xValue to pro forma EBITDAIncluding the AMS deal
$33 / $59 / $84Sum-of-the-parts per shareBear, base and bull cases
68/100Highlight scoreFive tests, section 10

Disclosure: I do not own shares or options in H.B. Fuller, and I am not being paid by the company.

01Why This Stock

H.B. Fuller is a St. Paul, Minnesota maker of industrial adhesives, the glues and sealants that go into diapers, packaging, car parts, electronics and roofs. It had $3.47 billion of revenue in fiscal 2025, and its products are usually less than 2% of the cost of whatever they end up in. It is not a household name, and for most of the past four years it has not been a growth story either: revenue has been flat to down since fiscal 2022.

It reached this page because three separate signals lined up in the same quarter. Two activist funds, Ancora and Engine Capital, added heavily to their stakes in the three months to September 30, 2026, and several event-driven hedge funds opened or expanded positions alongside them. Every one of the eight independent directors then bought shares in the open market between September 28 and October 7. And the board has now rejected two cash offers for one of its three businesses, while Ancora has asked it to consider selling the whole company, with a deadline for board nominations opening on December 17.

The stock has not responded. It closed at $46.24 on November 20, 2026, its lowest close of the past year, and is down about 28% from its June high. You can follow its holders quarter by quarter on our H.B. Fuller ownership page.

H.B. Fuller weekly closing price, May 22 to November 20, 2026
H.B. Fuller weekly closing price, May 22 to November 20, 2026$48$52$56$60$64$68MayJunJulAugSepOctNov1234567$46.24
  1. 1 May 26: Ancora publicly opposes the AMS deal
  2. 2 June 25: H.B. Fuller agrees to buy AMS with Q2 results
  3. 3 August 12: Ancora bids $1.1-1.2B for the BAS unit; Engine letter Aug 14
  4. 4 August 24: Board rejects the first bid
  5. 5 September 28: Directors start buying; Ancora raises its bid Sep 29
  6. 6 October 19: Second bid rejected; "market check" announced
  7. 7 October 27: Ancora calls for a sale of the whole company
Friday closes (Yahoo Finance; the November 20 close also checked on StockAnalysis). Numbered markers are the dates in the activist timeline in section 04.
The short version
  • Hedge funds: Ancora roughly 3.8% and Engine roughly 1.7% of the company at September 30, after adding +63.5% and +120.3% in the quarter.
  • Insiders: $1.15 million of open-market buying from eight directors and one executive in three weeks, after a public letter from Engine criticised the board for not owning stock.
  • Catalysts: a "market check" on parts of the business due by the end of 2026, the nomination window from December 17 to January 16, the AMS deal closing, and fiscal 2027 guidance in January.
  • Valuation: about 7.7 times pro forma earnings before interest, tax, depreciation and amortization (EBITDA), against 9 to 11 times in the activists' private-market estimates.
  • The catch: volumes are falling, debt will be about four times EBITDA once the AMS deal closes, and free cash flow has fallen three years running.

02The Hedge Funds Behind It

The 13F filings for the quarter to September 30, 2026 show two groups moving in opposite directions. Growth and quality managers cut: Kayne Anderson Rudnick reduced its stake by about a quarter and Fidelity by about a third. Activist and event-driven money went the other way.

Ancora Advisors, the Cleveland firm that has run the public campaign, held 2,056,536 shares at September 30, up +63.5% on the quarter and about 3.82% of the company. Ancora's 13F book runs to roughly 2,200 positions, most of them index-sized, so a stake of this size stands out as a deliberate bet. Engine Capital held 892,947 shares, up +120.3%, about 1.66% of the company; Engine describes itself as owning about 2%, which may include positions that 13F filings do not show. Together the two own roughly 5.5%. Neither has filed a Schedule 13D, which is required only when an investor or a group acting together passes 5%.

Others joined them. Luminus Management more than doubled its stake, to a position worth about 12% of its 13F book. Canyon Capital opened a new position. Millennium Management built its stake from a small one to about 721,000 shares. Among the long-term holders, Neuberger Berman added about 11% and Minnesota-based Mairs & Power trimmed slightly.

Funds on our Smart Money List

FundSignalShares, Q3 2026Shares, Q2 2026ChangeValue% of company
Ancora HoldingsHigh2,056,5361,257,802+63.5%$101.7M3.82%
Engine CapitalHigh892,947405,349+120.3%$44.2M1.66%
Millennium ManagementLow721,02043,505+1,557.3%$35.7M1.34%
Qube Research & TechnologiesLow415,43645,545+812.1%$20.6M0.77%
Canyon PartnersLow344,3590New$17.0M0.64%
Gabelli Funds / GAMCO InvestorsMedium301,000301,000Unchanged$14.9M0.56%
Polar Asset Management PartnersLow228,00082,800+175.4%$11.3M0.42%
AQR Capital ManagementLow174,184110,874+57.1%$8.6M0.32%
Tudor Investment CorporationMedium164,1430New$8.1M0.30%
Arrowstreet CapitalLow161,894224,784-28.0%$8.0M0.30%
Citadel AdvisorsLow142,07130,212+370.2%$10.7M0.26%
Woodline PartnersLow120,479113,479+6.2%$6.0M0.22%
Two Sigma InvestmentsLow117,9030New$5.8M0.22%
Susquehanna International GroupLow90,9087,912+1,049.0%$5.4M0.17%
Bridgewater AssociatesLow72,6093,761+1,830.6%$3.6M0.13%
Point72 Asset ManagementLow45,1630New$2.2M0.08%
Brevan Howard Asset ManagementLow42,52513,820+207.7%$2.1M0.08%
Freestone Grove PartnersLow23,3055,715+307.8%$1.2M0.04%
Winton GroupLow18,7003,900+379.5%$925K0.03%
Holocene AdvisorsMedium17,1270New$847K0.03%
Balyasny Asset ManagementLow16,72052,994-68.4%$827K0.03%
Engineers GateLow13,62031,603-56.9%$674K0.03%
Graham Capital ManagementLow10,8189,567+13.1%$535K0.02%
Man GroupLow6,6160New$327K0.01%
Magnetar CapitalLow6,22430,067-79.3%$308K0.01%
Capstone Investment AdvisorsLow5,9546,063-1.8%$295K0.01%
Marshall WaceLow4,4004,911-10.4%$218K0.01%
Squarepoint CapitalLow048,284Sold out--
Adage Capital ManagementLow010,000Sold out--
Voloridge Investment ManagementLow094,172Sold out--
Jane Street GroupLow027,590Sold out--
ExodusPoint CapitalLow078,919Sold out--
Verition Fund ManagementLow0221,045Sold out--

Funds on our Smart Money Fund List that reported FUL at either quarter end. Signal is how closely each fund is followed. Value at the quarter-end price. Source: SEC 13F filings, our warehouse.

Who bought and who sold in Q3 2026

Biggest increases in FUL, Q3 2026
ManagerShares addedChangeShares held% of company
Ancora Holdings Smart Money List+798,734+63.5%2,056,5363.82%
Millennium Management Smart Money List+677,515+1,557.3%721,0201.34%
Engine Capital Smart Money List+487,598+120.3%892,9471.66%
Qube Research & Technologies Smart Money List+369,891+812.1%415,4360.77%
DIMENSIONAL FUND ADVISORS LP+345,199+12.1%3,202,9375.95%
Canyon Partners Smart Money List+344,359New344,3590.64%
PRICE T ROWE ASSOCIATES INC /MD/+272,096+66.2%683,1631.27%
NEUBERGER BERMAN GROUP LLC+258,545+10.8%2,650,0354.92%
LUMINUS MANAGEMENT LLC+212,760+135.0%370,3160.69%
Lighthouse Investment Partners, LLC+196,025+88.8%416,7410.77%
Biggest cuts in FUL, Q3 2026
ManagerShares cutChangeShares held% of company
COOKE & BIELER LP-1,105,022Sold out00.00%
VICTORY CAPITAL MANAGEMENT INC-757,460-97.1%22,5850.04%
NORGES BANK-753,424Sold out00.00%
SILVERCREST ASSET MANAGEMENT GROUP LLC-690,706-98.9%7,4170.01%
BROWN ADVISORY INC-652,553-88.5%85,0550.16%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC-526,841-26.3%1,474,8862.74%
FMR LLC-353,913-32.6%731,8371.36%
First Eagle Investment Management, LLC-277,743-40.9%400,9430.74%
Verition Fund Management Smart Money List-221,045Sold out00.00%
Capital World Investors-220,078Sold out00.00%

All 13F filers, Q2 2026 to Q3 2026. Index funds and banks move large blocks for reasons that have nothing to do with the company, so read these with the fund names in mind. Source: SEC 13F filings, our warehouse.

Ownership over time

Number of 13F filers holding FUL, by quarter
13F filers holding FUL0100200300400Q1 '23286Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26344
Source: SEC 13F filings, our warehouse. Latest quarter Q3 2026. Each bar counts the managers that reported a position at the quarter end.
Share of FUL held by funds on our Smart Money List, by quarter
Share of FUL held by Smart Money List funds0.0%3.8%7.5%11.2%15.0%Q1 '233.6%Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '2611.6%
Shares reported by the roughly 270 funds on our Smart Money Fund List, divided by the shares outstanding the company reported to the SEC. Source: SEC 13F filings, our warehouse.

Short interest was 2.20 million shares, about 5.6% of the float, on October 30, 2026, down from 2.87 million a month earlier (Nexqual). Options traders are pricing a large move: implied volatility on February 2027 contracts was about 63% on November 20, roughly twice the stock's realised volatility over the past 30 days. To check any fund's other holdings, open its page from the tables above, or paste your own tickers into our Portfolio X-ray.

03Insiders Bought the Dip

On August 14, 2026, Engine published a letter saying the only independent director who had bought shares was the chair, Teresa Rasmussen, and that her purchase was more than four years old. Four days later Rasmussen filed an amended Form 4 changing the code on a 1,000-share purchase at $65.83 on April 17, 2026 to an open-market buy. Six weeks after the letter, the directors bought.

Open-market purchases by H.B. Fuller insiders, September 28 to October 16, 2026
Open-market purchases by H.B. Fuller insiders, September 28 to October 16, 2026R. Bailly$500,000D. Florness$100,160S. Zaheer$100,119C. Lauber$99,985T. Rasmussen$99,984M. Happe$99,250T. Handley$98,820M. Malik$25,000C. Martin$22,998
Total $1,146,316. Eight directors and one senior vice president, from their Form 4 filings. Rasmussen and Zaheer each made two purchases; their amounts are combined.

Seven directors bought between September 28 and 30 at about $49 to $50 a share, most of them about $100,000 each. R. Jeffrey Bailly, the executive chair of UFP Technologies who joined the board on September 23, bought $500,000 at $50.00 on October 7. Shahbaz Malik, who runs the building adhesives business that Ancora wants to buy, added $25,000 on October 16. The chief executive, Celeste Mastin, made open-market purchases in April 2025 and April 2026, of $198,310 and $295,104.

Two things temper the signal. The buying followed public criticism, so some of it is a response to Engine, and the amounts are modest: after buying, most directors hold 2,000 to 4,000 shares directly. And executives have kept selling. The chief financial officer sold $857,764 in October 2025, and Nathan Weaver, executive vice president for business transformation, sold in November 2025, August 2026 and again on November 11, 2026 at $50.42. Over the two years to November 21, 2026, open-market purchases came to $1,707,377 and sales to $2,678,843. Every trade is listed below, and current filings are on our insider trading pages.

DateInsiderRoleTypeSharesPriceValue
Nov 11, 2026Nathan D. WeaverExecutive VP, Business TransformationSale1,200$50.42$60,510
Oct 16, 2026Muhammad Shahbaz MalikSenior VP, Building Adhesive SolutionsBuy478.66$52.23$25,000
Oct 7, 2026R. Jeffrey BaillyDirectorBuy10,000$50.00$500,000
Sep 30, 2026Celine Christine MartinDirectorBuy464.6$49.50$22,998
Sep 29, 2026Srilata ZaheerDirectorBuy40$49.97$1,999
Sep 29, 2026Charles T. LauberDirectorBuy2,005$49.87$99,985
Sep 29, 2026Michael J. HappeDirectorBuy2,000$49.62$99,250
Sep 28, 2026Srilata ZaheerDirectorBuy2,000$49.06$98,120
Sep 28, 2026Teresa J. RasmussenDirector (Chair)Buy500$48.98$24,490
Sep 28, 2026Teresa J. RasmussenDirector (Chair)Buy1,542$48.96$75,494
Sep 28, 2026Thomas W. HandleyDirectorBuy2,000$49.41$98,820
Sep 28, 2026Daniel L. FlornessDirectorBuy2,030$49.34$100,160
Aug 11, 2026Nathan D. WeaverExecutive VP, Business TransformationSale9,561$62.06$593,332
Apr 17, 2026Teresa J. RasmussenDirector (Chair)Buy1,000$65.83$65,830
Apr 7, 2026Celeste Beeks MastinPresident and CEOBuy5,170$57.08$295,104
Nov 13, 2025Nathan D. WeaverExecutive VP, Business TransformationSale7,075$58.38$413,018
Oct 27, 2025John J. CorkreanExecutive VP and CFOSale14,222$60.31$857,764
Sep 26, 2025James J. EastExecutive VP, HHCBuy31$58.62$1,817
Aug 8, 2025Joao MagalhaesSenior VP, Engineering AdhesivesSale1,099$56.31$61,890
Aug 7, 2025Joao MagalhaesSenior VP, Engineering AdhesivesSale1,046$56.20$58,788
Jul 10, 2025Robert J. MartschingVP, Corporate ControllerSale9,546$64.30$613,852
Apr 1, 2025Celeste Beeks MastinPresident and CEOBuy3,500$56.66$198,310
Jan 28, 2025Xinyu DuSenior VP, Global R&DSale69$63.68$4,394
Jan 27, 2025Xinyu DuSenior VP, Global R&DSale240$63.73$15,295

Open-market purchases and sales only (Form 4 codes P and S), November 2024 to November 21, 2026. Option exercises, tax withholding and grants are left out. Each value links to the SEC filing. Download the trades (CSV)

04The Activist Campaign, Step by Step

2026What happenedSource
May 26Ancora publicly opposes H.B. Fuller's pursuit of Advanced Medical Solutions (AMS), a UK wound-care company, and asks for a strategic review that includes a sale.BusinessWire
Jun 10Engine writes privately to oppose the deal, valuing AMS at about 15.5 times EBITDA against about 8 times for H.B. Fuller.Engine
Jun 24-25H.B. Fuller announces the AMS purchase with its second-quarter results and raises guidance. Ancora condemns the deal; Engine says the stock fell about 11% over the next five days.BusinessWire
Aug 12Ancora makes a public cash offer of $1.1 billion to $1.2 billion for the Building Adhesive Solutions (BAS) business, with no financing condition.BusinessWire
Aug 14Engine publishes its letter, asking for market checks on BAS and on the whole company.Engine
Aug 24The board rejects the first offer; Ancora reaffirms it.BusinessWire
Sep 23Director Ruth Kimmelshue resigns; R. Jeffrey Bailly joins the board.8-K
Sep 29Ancora raises its offer to $1.2 billion to $1.4 billion, backed by a "highly confident" financing letter from Fortress, and puts the price at 8.5 to 9.9 times BAS earnings.BusinessWire
Oct 19The board unanimously rejects the second offer and announces a "market check" for select segments and product lines it considers less central, with any proceeds used to cut debt, to be completed by the end of 2026.8-K
Oct 27Ancora asks the board to run a full review of strategic alternatives, including a sale of the entire company, and says it is reserving its rights on "upcoming deadlines" and on making an offer for the whole of H.B. Fuller.BusinessWire
Nov 16The corporate controller resigns, staying through January 2027.8-K

The "upcoming deadlines" are almost certainly the nomination window for the 2027 annual meeting. Under the company's bylaws, shareholders who want to nominate directors must give notice between December 17, 2026 and January 16, 2027 (2026 proxy statement). As of November 21, 2026 there was no Schedule 13D, proxy filing or nomination notice from either fund on EDGAR, and no settlement had been announced.

Any contest has limits. The board is classified: its nine directors serve staggered three-year terms, so only three seats (Thomas Handley, Srilata Zaheer and Bailly) are up at the 2027 meeting. Even a clean sweep would not give the activists a majority. That makes a settlement, such as new directors and a review committee, the outcome activists often reach in situations like this, and Ancora has signed cooperation agreements with other companies before.

05The Business

H.B. Fuller reports three businesses. Hygiene, Health and Consumable (HHC) supplies adhesives for diapers and other nonwovens, packaging, tapes, labels and, increasingly, medical products. Engineering Adhesives (EA) serves electronics, cars, aerospace and solar. Building Adhesive Solutions (BAS) sells roofing adhesives, construction sealants and insulating-glass materials, and is the unit Ancora has bid for.

Adjusted EBITDA by business, last twelve months to August 29, 2026 ($ millions)
Adjusted EBITDA by business, last twelve months to August 29, 2026 ($ millions)Hygiene, Health and Consumable$266.6MEngineering Adhesives$243.3MBuilding Adhesive Solutions$141.0MAMS (pending purchase)$57M
Last twelve months = fiscal 2025 plus the first nine months of fiscal 2026, less the same nine months of fiscal 2025, from the 10-K and the Q3 10-Q. The AMS figure is the company's own (October 6, 2026 presentation).

Third-quarter results, for the quarter ended August 29, 2026, show the pattern of the past two years. Revenue rose 5.2% to $938.2 million and adjusted earnings per share rose 21% to $1.52, ahead of the $1.46 analysts expected. But all of the growth came from higher prices: volumes fell 3.0%, and fell in every business.

What moved third-quarter revenue (change from a year earlier)
What moved third-quarter revenue (change from a year earlier)Price+7.4%Volume-3.0%Currency+0.7%Acquisitions+0.1%Total+5.2%
Quarter ended August 29, 2026. Source: H.B. Fuller third-quarter results, September 23, 2026.
FY2023FY2024FY2025Last 12 months
Net revenue$3,510.9M$3,568.7M$3,473.6M~$3,554M
Adjusted EBITDA~$581M$593.9M$620.7M~$657M
Adjusted EBITDA margin16.5%16.6%17.9%~18.5%
Operating cash flow$378.4M$302.4M$263.5M-
Capital spending$119.1M$139.2M$142.3M-
Free cash flow$259.3M$163.2M$121.2M~$100M

Sources: fiscal 2025 10-K, third-quarter 10-Q, third-quarter results. Last-twelve-month free cash flow is an estimate from Nexqual's SEC-derived tables.

Margins have risen about 2.5 percentage points since fiscal 2023 through price increases, a better mix and cost cuts, and the company has beaten analysts' earnings estimates four quarters running. Free cash flow has gone the other way, from $259 million in fiscal 2023 to about $100 million over the latest twelve months, as working capital grew: customers took 63 days to pay against 58 a year earlier, and inventory rose to 88 days from 78.

Guidance for fiscal 2026, which ends November 28, is adjusted EBITDA of $655 million to $670 million and adjusted earnings per share of $4.70 to $4.85. That implies $1.20 to $1.35 for the fourth quarter, below the $1.36 analysts expect (Nexqual), and estimates for fiscal 2027 have been cut from $5.32 to $5.15 over the past 90 days.

06Debt and the AMS Deal

The AMS purchase is the reason the activists went public. H.B. Fuller agreed to pay 285 pence a share in cash, about $892 million for the equity and about 15.5 times AMS's 2026 EBITDA by Engine's count, a 35% premium. AMS shareholders approved it on August 12 (84.2% in favour), most regulators have cleared it, and the company expects to complete it in the fourth quarter of calendar 2026. The deal must close by June 25, 2027.

To pay for it, H.B. Fuller sold $850 million of 7.625% notes due 2034 in October and is extending and enlarging its term loan. The company's own pro forma figures show what that does to the balance sheet:

August 29, 2026 (actual)After AMS (pro forma)
Cash$97M$118M
Total debt$2,055M (3.1x)$3,097M (4.3x)
Net debt$1,957M (3.0x)$2,979M (4.2x)
Last-12-month adjusted EBITDA$657M$713M

Multiples are net debt or debt divided by last-twelve-month adjusted EBITDA. Source: October 6, 2026 investor presentation; note terms from the October 22, 2026 8-K.

Management says leverage will be about 4.0 times at closing and that it intends to reduce it over two years. The covenants are not the constraint: secured debt was 2.2 times EBITDA at August 29 against a limit of 4.5 times. The pressure comes from the cost: the new notes alone carry about $65 million a year of interest, and the 7.625% coupon shows what lenders now charge this company. Getting back to the 2.5 to 3.0 times that Ancora and, earlier, management talked about would take $0.8 billion to $1.1 billion of debt repayment, several years of free cash flow at recent levels. That is why asset sales sit at the centre of the debate: selling BAS for $1.2 billion to $1.4 billion would bring leverage down to about 2.9 times by my estimate, before any tax on the sale.

If AMS does not close by June 25, 2027 (extendable to October 21, 2027), $450 million of the new notes must be redeemed at par.

07What It Could Be Worth

At $46.24 the company is worth about $2.49 billion in the market. Adding the pro forma net debt of $2.98 billion gives an enterprise value of about $5.47 billion, or 7.7 times pro forma EBITDA of $713 million (6.8 times before AMS). Ancora puts its BAS offer at 8.5 to 9.9 times that unit's earnings, and Engine estimates the whole company would sell for 9 to 11 times. Adhesive deals over the past decade have mostly been struck at 11 to 15 times or more.

YearDealPriceMultiple of EBITDA
2017H.B. Fuller buys Royal Adhesives & Sealants (8-K)$1.575B11.4x
2021-22Arkema buys Ashland Performance Adhesives (Ashland)$1.65B~20x
2021-23Sika buys MBCC (Sika)CHF ~5.5B11.5x
2026H.B. Fuller agrees to buy AMS (Engine's estimate)~GBP 715M~15.5x
2026Ancora's rejected offer for BAS$1.2-1.4B8.5-9.9x
Nov 20, 2026H.B. Fuller in the stock market, pro forma$5.47B7.7x

A sum-of-the-parts estimate values each business separately and subtracts the debt. Because debt is large next to the market value, each turn of EBITDA multiple is worth about $13.25 a share, which is why the cases spread so widely.

Value per share under each case, against the November 20, 2026 close
Value per share under each case, against the November 20, 2026 closeBear case$32.68Base case$58.88Bull case (break-up values)$83.62Sale of the company at 9x$63.88Sale of the company at 10x$77.13Sale of the company at 11x$90.38Nov 20 close $46.24
My calculation from the segment figures above, pro forma net debt of $2,979 million (October 6, 2026 presentation) and 53.818 million shares. Pension and other liabilities and any tax on a sale are not deducted.
BusinessLast-12-month EBITDABearBaseBull
Hygiene, Health and Consumable$266.6M6.5x8.0x10.0x
Engineering Adhesives$243.3M7.5x9.0x11.0x
Building Adhesive Solutions$141.0M6.5x8.5x9.9x
AMS$57M9x11x13x
Enterprise value$4,738M$6,148M$7,479M
Value per share$32.68$58.88$83.62

The bear case also cuts every business's EBITDA by 5% for a volume recession. The base multiple for BAS is close to the low end of Ancora's offer and the bull multiple matches the high end. Download the calculation (CSV)

Wall Street's view is less dramatic: six of the seven analysts who cover the stock rate it a buy, with an average target of $66.29, but five of them cut their targets between September 25 and October 21, 2026 (Nexqual).

08Dates to Watch

DateEventWhy it matters
November 28, 2026Fiscal 2026 endsSets the base for fiscal 2027 guidance
By December 31, 2026Result of the "market check" on select segments and product linesSize of any sale and how much debt it repays
Fourth quarter of 2026AMS completion (court sanction date not yet announced)Leverage rises to about 4 times
December 17, 2026 to January 16, 2027Nomination window for the 2027 annual meetingProxy fight or settlement
Mid-January 2027 (expected)Fourth-quarter results and fiscal 2027 guidanceLast year's report came on January 14
February 15, 2027$300 million of 4% notes matureAlready covered by the AMS financing
April 2027 (expected)Annual meeting; three board seats upThe 2026 meeting was on April 16
June 25, 2027Deadline for AMS to close$450 million of notes redeemed if it does not

09Risks

  • Volume. Volumes fell 3.0% in the third quarter and 3.3% over nine months, in every business. If price increases fade while volumes keep falling, the margin gains reverse.
  • Debt. About 4 times EBITDA after AMS, with $850 million at 7.625%.
  • Cash. Free cash flow of about $100 million over the past twelve months, with restructuring spending continuing into fiscal 2028.
  • AMS. A cross-border deal at about 15.5 times EBITDA; AMS's US LiquiBand sales fell 15% in the first half of 2026.
  • The board can wait. With a classified board, a single proxy contest cannot change control, and the October 19 rejection was unanimous.
  • The activists own about 5.5%. A settlement could add directors without changing the strategy.
  • Expectations. Analysts' fourth-quarter estimate sits above the top of what guidance implies.
What would change the picture
  • A settlement with no commitment to a strategic review or a meaningful asset sale.
  • Fiscal 2027 guidance with volumes down again and margins under pressure.
  • A credit rating downgrade, a dividend cut or another large acquisition.
  • On the other side: a Schedule 13D, director nominations, a sale of BAS or another unit at 9 times or more, or an offer for the whole company.

10How It Scores

Every Hedge Fund Highlight is scored out of 100 on the same five tests, so reports can be compared over time.

TestWeightScoreWhy
Hedge fund buying2520Ancora and Engine added heavily; Luminus, Canyon, Millennium and others joined. Fidelity and Kayne cut.
Insider buying2012All eight independent directors and one executive bought, but after public criticism, in small amounts, while executives sold.
Business momentum209Earnings beats from price and margin; volumes down, free cash flow down, estimates cut.
Catalysts2017Two rejected bids, a call for a sale, a market check due by year end and a nomination window from December 17.
Valuation and risk15107.7 times pro forma EBITDA against 9 to 11 times in private-market estimates, offset by leverage.
Total10068

11How I Put This Together

Hedge Fund Highlight stocks come from a weekly screen of the roughly 270 funds on our Smart Money Fund List: stocks that several of them bought in the latest 13F quarter, checked for open-market insider buying (Form 4), activist stakes (Schedule 13D) and the state of the business from SEC financial data. The tables of funds and the ownership charts in section 02 are drawn from the same 13F warehouse as the rest of this section and update when new filings arrive; the rest of the report is as of the dates shown.

Company figures come from H.B. Fuller's SEC filings (10-K, 10-Q, proxy) and its October 6, 2026 investor presentation. Activist statements are from the funds' own releases and letters. Market data (short interest, options, analyst targets and estimates, peer valuations) is from Nexqual at the November 20, 2026 close. Insider trades were read from each Form 4 on EDGAR. The sum-of-the-parts values, leverage paths and the score are my own calculations and judgement. Where a figure could not be confirmed from a filing it was left out.

12Corrections and Updates

  • November 21, 2026: First published, with prices at the November 20, 2026 close.

This report is research drawn from public filings and is not investment advice or a recommendation to buy or sell any security. I do not own shares or options in H.B. Fuller, and I am not being paid by the company. 13F filings show long US equity positions at each quarter end and are filed up to 45 days later; they do not show short positions or most derivatives, so a fund's full exposure can differ.

All highlights · Every DaveManuel.com report